Filing Details
- Accession Number:
- 0001179110-15-013219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-11 08:46:38
- Reporting Period:
- 2015-09-09
- Filing Date:
- 2015-09-11
- Accepted Time:
- 2015-09-11 08:46:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1544227 | Ovascience Inc. | OVAS | Pharmaceutical Preparations (2834) | 451472564 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1272360 | Mary Fisher | C/O Ovascience, Inc. 215 First Street, Suite 240 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-09-09 | 6,100 | $16.49 | 6,415 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.42 to $16.51, inclusive. The Reporting Person undertakes to provide OvaScience, Inc., any security holder of OvaScience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges sent forth in this footnote.